Trial Profile
A Open-label, Randomized, Single Dose, Crossover Clinical Trial to Assess the Effect of Food on the Pharmacokinetics of YHD1119 in Healthy Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Jul 2021
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary)
- Indications Neuropathic pain
- Focus Pharmacokinetics
- Sponsors Yuhan
- 10 Jul 2021 Results assessing the effect of food on the pharmacokinetic profile of the pregabalin SR formulation after a single dose in healthy individuals published in the Clinical Therapeutics
- 14 Jan 2019 Status changed from recruiting to completed.
- 26 Jun 2017 Planned End Date changed from 30 Jun 2017 to 30 Oct 2017.